Hicks RJ - Search Results

1

High-Specific-Activity-¹³¹I-MIBG versus ¹⁷⁷Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.

Jha A, Taïeb D, Carrasquillo JA, Pryma DA, Patel M, Millo C, de Herder WW, Del Rivero J, Crona J, Shulkin BL, Virgolini I, Chen AP, Mittal BR, Basu S, Dillon JS, Hope TA, Mari Aparici C, Iagaru AH, Hicks RJ, Avram AM, Strosberg JR, Civelek AC, Lin FI, Pandit-Taskar N, Pacak K. Jha A, et al. Among authors: hicks rj. Clin Cancer Res. 2021 Jun 1;27(11):2989-2995. doi: 10.1158/1078-0432.CCR-20-3703. Epub 2021 Mar 8. Clin Cancer Res. 2021. PMID: 33685867 Free PMC article. Review.

2

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.

Loi S, Ngan SY, Hicks RJ, Mukesh B, Mitchell P, Michael M, Zalcberg J, Leong T, Lim-Joon D, Mackay J, Rischin D. Loi S, et al. Among authors: hicks rj. Br J Cancer. 2005 Feb 28;92(4):655-61. doi: 10.1038/sj.bjc.6602413. Br J Cancer. 2005. PMID: 15700033 Free PMC article. Clinical Trial.

3

The role of PET in monitoring therapy.

Hicks RJ. Hicks RJ. Cancer Imaging. 2005 Jun 21;5(1):51-7. doi: 10.1102/1470-7330.2005.0006. Cancer Imaging. 2005. PMID: 16154820 Free PMC article.

4

Functional imaging techniques for evaluation of sarcomas.

Hicks RJ. Hicks RJ. Cancer Imaging. 2005 Jun 21;5(1):58-65. doi: 10.1102/1470-7330.2005.0007. Cancer Imaging. 2005. PMID: 16154821 Free PMC article.

5

Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.

Cachin F, Prince HM, Hogg A, Ware RE, Hicks RJ. Cachin F, et al. Among authors: hicks rj. J Clin Oncol. 2006 Jul 1;24(19):3026-31. doi: 10.1200/JCO.2005.04.6326. Epub 2006 May 22. J Clin Oncol. 2006. PMID: 16717291 Clinical Trial.

6

Role of PET-CT in the optimization of thoracic radiotherapy.

Mac Manus M, Hicks RJ, Everitt S. Mac Manus M, et al. Among authors: hicks rj. J Thorac Oncol. 2006 Jan;1(1):81-4. J Thorac Oncol. 2006. PMID: 17409833 Free article. Review.

7

Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy.

Hicks RJ. Hicks RJ. Cancer Imaging. 2010 Oct 4;10 Spec no A(1A):S83-91. doi: 10.1102/1470-7330.2010.9007. Cancer Imaging. 2010. PMID: 20880795 Free PMC article. Review.

8

Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma.

Brettingham-Moore KH, Duong CP, Greenawalt DM, Heriot AG, Ellul J, Dow CA, Murray WK, Hicks RJ, Tjandra J, Chao M, Bui A, Joon DL, Thomas RJ, Phillips WA. Brettingham-Moore KH, et al. Among authors: hicks rj. Clin Cancer Res. 2011 May 1;17(9):3039-47. doi: 10.1158/1078-0432.CCR-10-2915. Epub 2011 Jan 11. Clin Cancer Res. 2011. PMID: 21224373

9

Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib.

Mileshkin L, Hicks RJ, Hughes BG, Mitchell PL, Charu V, Gitlitz BJ, Macfarlane D, Solomon B, Amler LC, Yu W, Pirzkall A, Fine BM. Mileshkin L, et al. Among authors: hicks rj. Clin Cancer Res. 2011 May 15;17(10):3304-15. doi: 10.1158/1078-0432.CCR-10-2763. Epub 2011 Mar 1. Clin Cancer Res. 2011. PMID: 21364032 Clinical Trial.

10

Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.

Siva S, Herschtal A, Thomas JM, Bernshaw DM, Gill S, Hicks RJ, Narayan K. Siva S, et al. Among authors: hicks rj. Cancer. 2011 Sep 1;117(17):3981-8. doi: 10.1002/cncr.25991. Epub 2011 Mar 1. Cancer. 2011. PMID: 21365626 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

585 results

Search Page